Routine venoarterial extracorporeal membrane oxygenation for acute myocardial infarction-related cardiogenic shock: what we know and don’t know
Uložené v:
| Názov: | Routine venoarterial extracorporeal membrane oxygenation for acute myocardial infarction-related cardiogenic shock: what we know and don’t know |
|---|---|
| Autori: | Holger Thiele, Jan Belohlavek, Christian Hassager |
| Zdroj: | Intensive Care Med Thiele, H, Belohlavek, J & Hassager, C 2024, ' Routine venoarterial extracorporeal membrane oxygenation for acute myocardial infarction-related cardiogenic shock : what we know and don’t know ', Intensive Care Medicine, vol. 50, no. 8, pp. 1354-1357 . https://doi.org/10.1007/s00134-024-07517-1 |
| Informácie o vydavateľovi: | Springer Science and Business Media LLC, 2024. |
| Rok vydania: | 2024 |
| Predmety: | Extracorporeal Membrane Oxygenation, Myocardial Infarction/therapy [MeSH], Shock, Cardiogenic/etiology [MeSH], Shock, Cardiogenic/therapy [MeSH], What's New in Intensive Care, Extracorporeal Membrane Oxygenation/methods [MeSH], Myocardial Infarction/complications [MeSH], Humans [MeSH], Shock, Cardiogenic, Myocardial Infarction, Humans, 3. Good health |
| Popis: | Acute myocardial infarction-related cardiogenic shock (AMI-CS) carries a dismal prognosis. Short-term mortality is in the range of 40–50% [1]. Until recently, only treatment of the culprit lesion by percutaneous coronary intervention (PCI) reduced mortality within randomized controlled trials (RCT) [1]. High expectations have been placed on venoarterial extracorporeal membrane oxygenation (VA-ECMO) and its use has risen by up to 40 times in the last decade despite a lack of relevant evidence from RCTs [2].The concept is to provide temporary partial or complete circulatory and also respiratory support during the critical first days as a bridge-to-recovery, bridge-to-decision, bridge-to-durable left ventricular assist device (LVAD), or bridge-to-transplantation. |
| Druh dokumentu: | Article Other literature type |
| Popis súboru: | application/pdf |
| Jazyk: | English |
| ISSN: | 1432-1238 0342-4642 |
| DOI: | 10.1007/s00134-024-07517-1 |
| Prístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/38916746 https://curis.ku.dk/ws/files/402280354/s00134_024_07517_1.pdf https://repository.publisso.de/resource/frl:6521741 |
| Rights: | CC BY NC URL: http://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (http://creativecommons.org/licenses/by-nc/4.0/) . |
| Prístupové číslo: | edsair.doi.dedup.....3a340063da3669d49c68ecb5f48a8a29 |
| Databáza: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | Acute myocardial infarction-related cardiogenic shock (AMI-CS) carries a dismal prognosis. Short-term mortality is in the range of 40–50% [1]. Until recently, only treatment of the culprit lesion by percutaneous coronary intervention (PCI) reduced mortality within randomized controlled trials (RCT) [1]. High expectations have been placed on venoarterial extracorporeal membrane oxygenation (VA-ECMO) and its use has risen by up to 40 times in the last decade despite a lack of relevant evidence from RCTs [2].The concept is to provide temporary partial or complete circulatory and also respiratory support during the critical first days as a bridge-to-recovery, bridge-to-decision, bridge-to-durable left ventricular assist device (LVAD), or bridge-to-transplantation. |
|---|---|
| ISSN: | 14321238 03424642 |
| DOI: | 10.1007/s00134-024-07517-1 |